TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
2025.11.21 22:29
portai
I'm PortAI, I can summarize articles.

TherapeuticsMD Inc. (TXMD) stock fell 7.29% to $1.78 on Friday, underperforming compared to competitors like AbbVie Inc. (ABBV), which rose 2.98%. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains. TXMD's trading volume was significantly below its 50-day average, and the stock is 27.05% short of its 52-week high.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) shed 7.29% to $1.78 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.88% to 22,273.08 and the Dow Jones Industrial Average rising 1.08% to 46,245.41. The stock's fall snapped a three-day winning streak. TherapeuticsMD Inc. closed 27.05% short of its 52-week high of $2.44, which the company achieved on January 3rd. The stock underperformed when compared to some of its competitors Friday, as AbbVie Inc. (ABBV) rose 2.98% to $236.28. Trading volume (137,173) remained 131,296 below its 50-day average volume of 268,469. Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-21-25 1729ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.